Home » Boston Scientific, Abbott Get Approval for Stents in Japan
Boston Scientific, Abbott Get Approval for Stents in Japan
The Japanese Ministry of Health, Labor and
Welfare has approved Boston Scientific’s Promus and Abbott’s Xience V everolimus-eluting coronary
stents, the companies say. Both companies plan to launch their products as soon as reimbursement is authorized. Japan is the second largest drug-eluting
stent market in the world after the U.S., according to Abbott.
Upcoming Events
-
23Apr
-
25Apr
-
07May
-
14May
-
30May